WS #11077
PetMed Express confirms receipt of unsolicited $3/share acquisition proposal from SilverCape Investments. European Commission opens antitrust investigation into Align Technology's conduct regarding Invisalign clear aligners and intra-oral scanners. US lawmakers probe Merck and AbbVie over national security and ethical risks tied to clinical trials conducted in China.
PetMed Express Acquisition Proposal
PetMed Express confirms receipt of unsolicited $3/share acquisition proposal from SilverCape Investments.
European Commission opens antitrust investigation into Align Technology's conduct regarding Invisalign clear aligners and intra-oral scanners.
US lawmakers probe Merck and AbbVie over national security and ethical risks tied to clinical trials conducted in China.